Ontology highlight
ABSTRACT:
SUBMITTER: Su Z
PROVIDER: S-EPMC7710644 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Su Zhaoqian Z Wang Bo B Almo Steven C SC Wu Yinghao Y
iScience 20201120 12
Immunotherapeutics are frequently associated with adverse side effects due to the elicitation of global immune modulation. To lower the risk of these side effects, recombinant DNA technology is employed to enhance the selectivity of cell targeting by genetically fusing different biomolecules, yielding new species referred to as multi-specific biologics. The design of new multi-specific biologics is a central challenge for the realization of new immunotherapies. To understand the molecular determ ...[more]